FDBusiness.com

Biotech Company Nuritas Discovers New MRSA Killing Peptide

 Breaking News
  • Pernod Ricard to Acquire Super-premium Italian Gin Brand Pernod Ricard is acquiring Italian super-premium gin brand Malfy from Biggar & Leith for an undisclosed price. Malfy is a range of super-premium gins distilled by the Vergnano family in the Italian region of Moncalieri, and already present in several international markets such as the United States, United Kingdom and Germany. Each gin in the [...]...
  • Nestlé and Carrefour Give Consumers Access to Blockchain Platform Nestlé and Carrefour, the French retail group, have announced that they are giving consumers access to blockchain data for Mousline purée in France. This is the first time that Nestlé is sharing information on its products with consumers via a blockchain platform. Consumers can use their smartphone or other device to scan a QR code on [...]...
  • Plastics Action Alliance Sets Targets to Achieve Sustainable Reduction in Use of Plastic in Ireland Plastics Action Alliance, the recently formed group that comprises of 11 leading agricultural processing and food businesses in Ireland, has set out its key objectives. The industry leading group aims to significantly reducing the use of plastic packaging across its members’ operations. Formed at the end of 2018, the Plastics Action Alliance is a collaboration that [...]...
  • Carlsberg UK Gets Honest About Its Beer Carlsberg UK has launched its most ambitious and honest consumer facing campaign ever in a bid to drive reappraisal of its flagship beer brand. Expected to reach 97% of the UK, the £20 million campaign conceived in collaboration with agency partners Fold7, Clifford French and Initiative – trades on the equity of the brand’s renowned [...]...
  • Alternative Proteins Challenge Dairy Dominance The value of the sports nutrition market is set to grow by around 8% per year to reach over US$17 billion globally in 2021, according to Innova Market Insights’ forecasts. The mainstreaming of the market has led to a surge in interest in plant-based alternatives with the traditional dominance of whey and other dairy proteins [...]...

Biotech Company Nuritas Discovers New MRSA Killing Peptide

December 06
15:42 2014

Nuritas PhotoIrish bioinformatics company, Nuritas, today announced that it has discovered an MRSA killing peptide. The peptide, which is derived from a food by-product, is anticipated to provide a natural, healthy innovation in the fight against antibiotic resistant infections in both humans and animals.

Nuritas’ ground-breaking biotechnology is capable of quickly and cost-effectively harvesting ingredients which then may be developed and supplied to humans and animal producers for many different applications from topical applications to effective cleaning biocides.

Dr. Nora Khaldi, CEO of Nuritas, states “Our aim is to make ingredients that are more accessible, natural and meeting serious societal health needs.”

Unlike existing MRSA killing products, Nuritas has found a way to rapidly and effectively extract and activate safe and healthy antimicrobial molecules in food that are often overlooked. This is a world first in that most molecules are usually derived from non-sustainable sources that have unknown side effects on human health and cost millions and years to develop.

Dr. Marta Martins, Biotechnology Research Fellow at University College Dublin said that “The increase of antibiotic resistance in bacteria of clinical relevance is a major issue for Public Health and there is the immediate need for alternative solutions”. Nuritas’ announcement today of the discovery of an effective and natural peptide to combat MRSA comes at a crucial point in the MRSA battle it seems.

Staphylococcus aureus is a bacterium commonly found in the nose and/or skin of healthy persons and animals. Strains of this bacterium that are resistant to beta-lactam antibiotics are called Methicillin-Resistant Staphylococcus aureus (MRSA). If this bacterium penetrates the skin and enters the blood stream it can cause life-threatening infections due to its resistance to many of the currently used antibiotics.

The inappropriate use of antibiotics in human treatments and animal production is contributing to antibiotic resistance, allowing bacterium such as Staphylococcus aureus to continue to evolve. Developing treatments to keep up with the evolution of the bacterium are costly and time-consuming. Severe side effects are also associated with some of the second or last-line antibiotic treatments. Nuritas’ ingredients are cost-effectively and quickly mined from food sources eliminating the possible severe side effects associated with current therapies and uses.

Overall, Nuritas’ discovery has the potential to provide innovative treatment of the costly and dangerous MRSA causing-infections by providing affordable, healthy, sustainable anti-microbials to ensure the healthy, long life of humans and animals.

 

About Nuritas

downloadNuritas is a biotechnology company that radically changes the way we discover natural peptides that target key receptors to actively promote and manage health. The company uses artificial intelligence to data mine food, allowing the discovery of life-changing ingredients that can be added to personal care products, supplements, food or biocides. Nuritas is committed to applying its scientific expertise to translate nature into healthy, sustainable and cost-effective living for all.

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • June 18, 2019Multimodal 2019
  • June 25, 2019BevExpo 2019
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements